152 related articles for article (PubMed ID: 11907436)
21. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.
Shen H; Alsatie M; Eckert G; Chalasani N; Lumeng L; Kwo PY
Clin Gastroenterol Hepatol; 2004 Apr; 2(4):330-6. PubMed ID: 15067628
[TBL] [Abstract][Full Text] [Related]
24. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and treatment of HBV reinfection following liver transplantation].
Yuan G; Duan Y; Wang F; Liang S; Zhu L
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):14-6. PubMed ID: 11856491
[TBL] [Abstract][Full Text] [Related]
26. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
27. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
Wang HF; Li L; Su HB; Ji W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005
[TBL] [Abstract][Full Text] [Related]
31. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL
Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533
[TBL] [Abstract][Full Text] [Related]
32. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
33. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
34. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
35. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Lim SG; Wai CT; Rajnakova A; Kajiji T; Guan R
Gut; 2002 Oct; 51(4):597-9. PubMed ID: 12235087
[TBL] [Abstract][Full Text] [Related]
36. How will we use the new antiviral agents for hepatitis B?
Perrillo RP
Curr Gastroenterol Rep; 2002 Feb; 4(1):63-71. PubMed ID: 11825543
[TBL] [Abstract][Full Text] [Related]
37. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
Yaşar DG; Suyanı E; Özenirler S; Sucak GT
Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Wolters LM; Honkoop P; Niesters HG; de Man RA
J Hepatol; 1998 May; 28(5):909-10. PubMed ID: 9625328
[No Abstract] [Full Text] [Related]
39. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
